Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Lilly's New Year Resolution: Make New Launches Into Blockbusters

Dec 20 2018

• By Jessica Merrill

Indianapolis - Circa April 2016: Eli Lilly and Company World Headquarters. Lilly makes Medicines and Pharmaceuticals IV - Image

Related Content

Lilly's Lasmiditan NDA Review Could Hinge On US FDA's Migraine Guidance

Nov 26 2018

$1.6bn ARMO Buy Gives Lilly Its Most Advanced Immuno-Oncology Asset

May 11 2018

Lilly Ready For More Risk When It Comes To Early Deals

Dec 19 2018

Migraine Market Gets Competitive With Second, Third CGRP Inhibitor Launches

Nov 10 2018

Lilly Prices Olumiant For JAK Battle, But Misses Approval For Higher Dose

Jun 02 2018

Related Companies

Eli Lilly and Company

Novartis AG

Pfizer Inc.

Regeneron Pharmaceuticals, Inc.

Teva Pharmaceutical Industries Ltd.

Johnson & Johnson

ARMO BioSciences, Inc.

Additional Topics

Business Strategies Commercial Companies BioPharmaceutical

More from Strategy

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window